View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Comment
March 7, 2022

How will the international sanctions affect the orthopaedic device market in Russia?

Exports of medical devices allowed by sanctions to Russia will continue, but in the face of larger economic forces.

By GlobalData Healthcare

In the week since Russia launched its invasion of Ukraine, the response from the international community has built momentum in the form of sweeping economic sanctions. A joint statement was made on 26 February reading: “We, the leaders of the European Commission, France, Germany, Italy, the United Kingdom, Canada, and the United States, condemn Putin’s war of choice and attacks on the sovereign nation and people of Ukraine.” The Russian market is being increasingly isolated with each new measure, as sanctions target the export of high-technology goods and Russian banking transactions.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Medical devices and technologies are unlikely to be broadly targeted, given humanitarian considerations. Specific diagnostic and advanced surgery equipment are certain to become snared in semi-conductor, laser, and other export restrictions. Exports of medical devices allowed by sanctions to Russia will continue, but in the face of larger economic forces.

The exclusion of Russia from SWIFT effectively prevents any transactions that use a Russian bank to interact with an international one. This vastly complicates procurement by any Russia-based entity from any medical device supplier that uses SWIFT accessible accounts. Orthopaedic device manufacturers with an international presence fall into this category almost exclusively.    

The ruble has dropped precipitously, shedding approximately 30% of its value, as widely reported by Reuters , with no real end to the volatility in sight. This reduced purchasing power means that medical device procurements are going to be more costly, and likely reduced in turn. Suppliers from countries that have not imposed sanctions, like Changzhou Meditech Trading Co., in China, are still going to pursue full value for their goods.

GlobalData had been projecting the Russian orthopaedic device market to account for $872 million in 2022, which is 1.6% of the expected global value of that market segment. The market leader is Zimmer Biomet Holdings , Inc., which is estimated to hold a 17% share of the orthopaedic devices segment. The trend points towards a significant decline in device revenue for the Russian market, though it is still too early to confidently assign upper and lower bounds.   

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network